CD274 and neoplasm: Papillary RCC patients with PD-L1-positive tumor cells were significantly associated with an increased risk of death (HR = 8.20, 95% CI 1.22–6.27; p = 0.0012) compared with patients with PD-L1-negative tumor cells.